These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33955350)

  • 1. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019.
    Yang X; Fang Y; Chen H; Zhang T; Yin X; Man J; Yang L; Lu M
    Epidemiol Psychiatr Sci; 2021 May; 30():e36. PubMed ID: 33955350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global trends and regional differences in the burden of anxiety disorders and major depressive disorder attributed to bullying victimisation in 204 countries and territories, 1999-2019: an analysis of the Global Burden of Disease Study.
    Hong C; Liu Z; Gao L; Jin Y; Shi J; Liang R; Maimaitiming M; Ning X; Luo Y
    Epidemiol Psychiatr Sci; 2022 Nov; 31():e85. PubMed ID: 36440549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the incidence and DALYs of anxiety disorders at the global, regional, and national levels: Estimates from the Global Burden of Disease Study 2019.
    Xiong P; Liu M; Liu B; Hall BJ
    J Affect Disord; 2022 Jan; 297():83-93. PubMed ID: 34678404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.
    He H; Liu Q; Li N; Guo L; Gao F; Bai L; Gao F; Lyu J
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e91. PubMed ID: 31928566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the prevalence and disability-adjusted life years of eating disorders from 1990 to 2017: results from the Global Burden of Disease Study 2017.
    Wu J; Liu J; Li S; Ma H; Wang Y
    Epidemiol Psychiatr Sci; 2020 Dec; 29():e191. PubMed ID: 33283690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990-2017.
    Safiri S; Kolahi AA; Cross M; Hill C; Smith E; Carson-Chahhoud K; Mansournia MA; Almasi-Hashiani A; Ashrafi-Asgarabad A; Kaufman J; Sepidarkish M; Shakouri SK; Hoy D; Woolf AD; March L; Collins G; Buchbinder R
    Arthritis Rheumatol; 2021 Apr; 73(4):702-714. PubMed ID: 33150702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.
    Krishnamurthi RV; deVeber G; Feigin VL; Barker-Collo S; Fullerton H; Mackay MT; O'Callahan F; Lindsay MP; Kolk A; Lo W; Shah P; Linds A; Jones K; Parmar P; Taylor S; Norrving B; Mensah GA; Moran AE; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
    Neuroepidemiology; 2015; 45(3):177-89. PubMed ID: 26505982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD Diarrhoeal Diseases Collaborators
    Lancet Infect Dis; 2017 Sep; 17(9):909-948. PubMed ID: 28579426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional and national burden of autism spectrum disorder from 1990 to 2019: results from the Global Burden of Disease Study 2019.
    Li Z; Yang L; Chen H; Fang Y; Zhang T; Yin X; Man J; Yang X; Lu M
    Epidemiol Psychiatr Sci; 2022 May; 31():e33. PubMed ID: 35535764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019.
    Chen H; Zhang TC; Yin XL; Man JY; Yang XR; Lu M
    Br J Dermatol; 2022 Apr; 186(4):673-683. PubMed ID: 34758111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017.
    Krishnamurthi RV; Ikeda T; Feigin VL
    Neuroepidemiology; 2020; 54(2):171-179. PubMed ID: 32079017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.
    Liu J; Wu Q; Hao Y; Jiao M; Wang X; Jiang S; Han L
    Hum Reprod; 2021 Mar; 36(4):1108-1119. PubMed ID: 33501984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national burden of blindness and vision loss due to common eye diseases along with its attributable risk factors from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
    Yang X; Chen H; Zhang T; Yin X; Man J; He Q; Lu M
    Aging (Albany NY); 2021 Aug; 13(15):19614-19642. PubMed ID: 34371482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017.
    Safiri S; Kolahi AA; Cross M; Carson-Chahhoud K; Hoy D; Almasi-Hashiani A; Sepidarkish M; Ashrafi-Asgarabad A; Moradi-Lakeh M; Mansournia MA; Kaufman JS; Collins G; Woolf AD; March L; Smith E
    Arthritis Rheumatol; 2020 Nov; 72(11):1916-1927. PubMed ID: 32755051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.